Zhiqiao Feng

The Current Evidence for the Treatment of Sepsis with Xuebijing Injection: Bioactive Constituents, Findings of Clinical Studies and Potential Mechanisms.

H. Shang, Min Li, Cheng-yu Li, 2020, Journal of ethnopharmacology.

Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials.

H. Shang, Min Li, Baoshan Liu, 2018, Journal of ethnopharmacology.

[The effect of Xuebijing injection for severe acute pancreatitis: a Meta analysis].

H. Shang, Ran Tian, Rui Zheng, 2015, Zhonghua wei zhong bing ji jiu yi xue.

[A prospective multicenter clinical study of Xuebijing injection in the treatment of sepsis and multiple organ dysfunction syndrome].

Qingquan Liu, Jie Gao, Lingbo Kong, 2015, Zhonghua wei zhong bing ji jiu yi xue.

Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial

Junhua Zhang, Lixin Xie, C. Yao, 2019, Trials.

Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial

C. Bai, Yuanlin Song, Wenke Zheng, 2016, Trials.

A real-world study on adverse drug reactions to Xuebijing injection: hospital intensive monitoring based on 93 hospitals (31,913 cases).

Yipin Fan, H. Shang, Rui Zheng, 2019, Annals of translational medicine.